PCCTech Minutes 2015 02 23: Difference between revisions
Jump to navigation
Jump to search
Tsoutherland (talk | contribs) No edit summary |
Tsoutherland (talk | contribs) No edit summary |
||
| Line 26: | Line 26: | ||
* Brian led discussion, reviewed actor/transaction diagrams | * Brian led discussion, reviewed actor/transaction diagrams | ||
* discussion resulted in clarity of actor/transaction definitions, and use of grouping | * discussion resulted in clarity of actor/transaction definitions, and use of grouping | ||
===Device Clinical Bridge (DCB)=== | ===Device Clinical Bridge (DCB)=== | ||
| Line 37: | Line 36: | ||
* Dave Stumpf/Jesse Shiah from AgilePoint discussed reasons for using BPEL and/or XPDL | * Dave Stumpf/Jesse Shiah from AgilePoint discussed reasons for using BPEL and/or XPDL | ||
* '''next action:''' for Dave to bring details to next session on market penetration levels for XPDL/BPEL vs BPMN | * '''next action:''' for Dave to bring details to next session on market penetration levels for XPDL/BPEL vs BPMN | ||
===DAF=== | |||
* Keith led international discussion | |||
** decision made to not proceed further with international DAF efforts as there really does not seem to be much to do | |||
* Alex/Dragon led IHE USA extension discussion | |||
** DAF US extension is mostly complete | |||
** next steps - develop testing tools | |||
** would like to test at Connectathon 2016 (CAT16) | |||
Revision as of 09:29, 23 February 2015
Attendees
- Keith Boone
- Alex Lippitt
- Isabelle G
- George Cole
- Mike Bohl
- Tone Southerland
- Thom Kuhn
- Chris Lindop
- Brian Reinhold
- Dave Stumpf
Minutes
Intro/Agenda Review
- Request to record and make available the DCB discussions for those unable to attend the sessions due to time zone differences
RECON on FHIR
- George led discussion, reviewed several sections, made some changes to document
- may need interaction with IHE-HL7 Joint Workgroup, in relation to using the provenance FHIR resource
- discussion around using PCC-1 Share Content
- will likely need a new transaction that provides more explicit/specific guidance
Remote Patient Monitoring (RPM)
- Brian led discussion, reviewed actor/transaction diagrams
- discussion resulted in clarity of actor/transaction definitions, and use of grouping
Device Clinical Bridge (DCB)
- Alex led discussion, reviewed actors/transactions diagrams
- actors and transactions we reworked based on committee feedback
- next action: Alex to apply changes to DCM document for follow up session
Workflow Discussion
- Keith led discussion, reviewed selection of BPMN as the standard of choice
- Dave Stumpf/Jesse Shiah from AgilePoint discussed reasons for using BPEL and/or XPDL
- next action: for Dave to bring details to next session on market penetration levels for XPDL/BPEL vs BPMN
DAF
- Keith led international discussion
- decision made to not proceed further with international DAF efforts as there really does not seem to be much to do
- Alex/Dragon led IHE USA extension discussion
- DAF US extension is mostly complete
- next steps - develop testing tools
- would like to test at Connectathon 2016 (CAT16)